| General Information of Drug Metabolite (DM) (ID: DM002739) |
| DM Name |
Peficitinib metabolite MH2
|
| Structure |
|
|
3D MOL is unavailable
|
2D MOL is unavailable
|
|
|
|
|
|
|
|
| Full List of Drug-Metabolizing Enzyme (DME) Related to This DM |
| DME(s) Producing This DM through Metabolism |
| DME Name |
DME ID |
Reactant |
Reaction |
Related Drug |
REF |
|
Sulfotransferase 2A1 (SULT2A1)
|
DME0074
|
| Unclear - Unclear |
Peficitinib
|
[1] |
|
|
|
|
|
|
|
| DME(s) Metabolizing This DM |
| DME Name |
DME ID |
Product |
Reaction |
Related Drug |
REF |
|
Nicotinamide N-methyltransferase (NNMT)
|
DME0445
|
| Unclear - Unclear |
Peficitinib
|
[1] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Full List of Drug(s) That Produce This DM By Metabolism |
| Peficitinib |
DR1774
|
Phase 4 |
Rheumatoid arthritis |
|
|
| References |
| 1 |
Pharmacokinetics and Safety of a Single Oral Dose of Peficitinib (ASP015K) in Japanese Subjects With Normal and Impaired Hepatic Function Clin Pharmacol Drug Dev. 2020 Aug;9(6):699-708. doi: 10.1002/cpdd.751.
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.
